Combined synopsis and solicitation
Provision of Bordetella-Free Baboons for Pertussis Infection and Vaccination Studies
75F40126Q00204
Food and Drug Administration, Food and Drug Administration. All Other Animal Production.
Response deadline
July 10, 2026 at 2:00 PM EDT
Closed 68 days ago. Posted June 29, 2026, first published June 25, 2026. Scheduled to archive July 25, 2026.
Description
As published on SAM.gov.
6/29/2026; See attached amendment 1 to the combined synopsis/solicitation. Pertussis is an acute, highly contagious, potentially life-threatening respiratory disease, caused by the Gram-negative bacterium Bordetella pertussis. The underlying factors leading to the failure of public health measures to control pertussis disease using currently licensed vaccines are poorly understood. A more complete understanding of this disease and of the mechanisms of vaccine-mediated protection is a critical public health need.
The baboon model of pertussis, developed in the laboratories of the Food and Drug Administration (FDA) Center for Biologics Evaluation and Research (CBER), is the only animal model of pertussis that recapitulates the disease as observed in human patients.
Refinement of the baboon model to include establishment of infection by means of natural transmission will enable a more refine evaluation of the differences between the licensed acellular pertussis vaccines that fail to prevent infection and the whole cell vaccines that reduce infection. The performance of this study requires the purchase and delivery of twenty, Bordetella-free baboons.
Publications
Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.
Points of contact
- David Kramerdavid.kramer@fda.hhs.gov
- Nick Sartainnick.sartain@fda.hhs.gov
Also open from this buyer
- Packaged Food Ingredient MonitoringSolicitationNAICS 518210Maryland75F40126Q00344Closes todaySep 16